FDA Inspection 780558 — Haupt Pharma Wuelfing GmbH
The FDA completed an inspection of Haupt Pharma Wuelfing GmbH on April 20, 2012 in Gronau (Leine). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 20, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gronau (Leine) (Germany)